EFPIA：2024年创新药物无法获得和延迟获得的根本原因：缩短等待时间（英文版）

The unprecedented speed of innovation exhibited over the last five years and the promise of the industry pipeline2 provide an important opportunity to improve outcomes for patients. There is common agreement that the value of innovation is realised only when patients benefit from advances in treatment. However, a significant number of medicines are not available across all European Union (EU) markets. 3 EFPIA has for many years looked at the length of time it takes for medicines to be made av